Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMedtronic
About this trial
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
Eligibility criteria
Qualifiers
None
Disqualifiers
Subject is indicated for implant or within 30 days post-implant of at least one Medtronic market-released product used for a pacing, sensing or defibrillation application
Subjects who participated in a qualifying study (IDE) of a Medtronic market-released product with complete implant and follow-up data and subject or appropriate legal guardian authorizes release of subject study data
Subjects who are, or will be inaccessible for follow-up
Subjects with exclusion criteria required by local law (EMEA only)
Trial design
Treatments tested in this trial
- Device
Treatment groups
No treatment groups listed
Locations
320Australia
Chermside Australia
Douglas Australia
Murdoch Australia
Southport Australia
Sponsors and collaborators
Medtronic
Lead sponsor
Source ClinicalTrials.gov